EKF Diagnostics

Manufactures analysers for the measurement of glucose, lactate, hemoglobin, hematocrit and HbA1c for GP surgeries, ph... read more

EKF Diagnostics Showcases New Handheld β-Ketone and Glucose Analyzer at AACC 2021

By LabMedica International staff writers
Posted on 27 Sep 2021

Image: STAT-Site WB Analyzer (Photo courtesy of EKF Diagnostics)

EKF Diagnostics (Penarth, Cardiff, UK) demonstrated its new STAT-Site WB dual analyte measurement system at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo.

The annual event held in Atlanta on September 26-30 by the American Association for Clinical Chemistry (AACC) showcased the cutting edge science and technology shaping the future of laboratory medicine. As EKF’s first face-to-face event since COVID-19 restrictions began, this was the premiere of the new handheld analyzer for reliable and efficient β-ketone and glucose measurement from whole blood in seconds. Visitors were able to see firsthand how easy it was to use the CLIA waived and CE marked device in professional settings to monitor the effectiveness of diabetes control programs.

EKF also introduced its newest hemoglobin analyzer for the US market, the Hemo Control, which provides near patient hemoglobin and hematocrit results in one test as quickly as 25 seconds. EKF’s team of point-of-care and central laboratory diagnostics experts at the event also highlighted the Lucica Glycated Albumin-L. Manufactured by Asahi Kasei Pharma, it is a specific test for glycated albumin (“GA”) and is FDA cleared for sale in the US. where it is sold exclusively by EKF Diagnostics. This established test enables intermediate term glycemic monitoring of diabetics over the preceding 2-3 weeks.

The STAT-Site WB and Lucica Glycated Albumin-L test were part of a suite of other diabetes care products that EKF showcased at 2021 AACC. These included its Beta-Hydroxybutyrate LiquiColor Assay (B-HB) and Nitro-Tab Ketone Tablets, both of which provide quick and simple tests for ketosis. Other product highlights on EKF’s stand for point-of-care and central laboratory testing included its hemoglobin analyzers, the hand-held DiaSpect Tm and the HemoPoint H2 which offers both hemoglobin and hematocrit results in one test within 30-60 seconds. Additional analyzers on show included the Biosen RUO glucose and lactate analyzer.

EKF also discussed its growing EKF Life Sciences business which provides contract manufacturing services, as well as manufacturing diagnostic enzymes for use in medical diagnostics, pharmaceuticals and industry. This follows recent significant investment in its longstanding fermentation facility in Elkhart, Indiana, where it has been manufacturing enzymes and related biomolecules from bacterial fermentation since 1983.

Related Links:
EKF Diagnostics